When hearing aids are no longer effective, Ryder Boen tries a cochlear implant. As it’s turned on, he’s overwhelmed by what ...

Note: All product prices listed are accurate as of the publication date. Forbes Health expert and medical reviewers do not ...

Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, social media, and new content verticals. Previously, she worked as a senior ...

The agency's decision is based on results from a clinical trial in which the treatment improved hearing in 80 percent of the ...

MPR spoke with Dr Daniela Carvalho, an investigator in the CHORD trial, the results form which formed the basis for the approval of Otarmeni.

The FDA has granted accelerated approval to Otarmeni™ (lunsotogene parvec-cwha), the first gene therapy for pediatric and adult patients with OTOF-related sensorineural hearing loss.

The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...

The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss ...

First FDA-approved gene therapy for hearing loss targets a rare inherited form of deafness Treatment restored hearing in most ...

A first-of-its-kind gene therapy that can restore hearing in children born deaf has just cleared its final hurdle—and, in a ...

Approval in severe-to-profound and profound OTOF -related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of ...

On a day in the fall of 2022, Snohomish resident Erik Martin, who is also a police officer, woke up and found that he lost ...